|
|
| Countries covered: Europe This Frost & Sullivan research service titled European Autoimmune Disease Therapeutics Market provides an overview of current treatment options, drugs in pipeline and technological advancements in the market. It also a complete analysis of key market drivers, restraints and revenues involved in the current rheumatoid arthritis and multiple sclerosis medications. In this research, Frost & Sullivan's expert analysts thoroughly examine the following therapeutics markets for rheumatoid arthritis and multiple sclerosis. This research service is available through our Pharmaceutical & Biotechnology Growth Partnership Services program. With this program you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
Autoimmune Disease Therapeutics Market to Gain from Increased Acceptance of Biologics by Physicians The European autoimmune diseases therapeutics market is set to witness sustained growth in the coming years. Autoimmune diseases are caused by body’s immune responses directed on its own tissues. The immune system is designed to attack the infections caused by foreign bacteria and viruses. However, in an autoimmune disease, the immune cells in the body recognise the body’s own tissues as ‘foreign’ and the antibodies released by the immune cells act on various tissues in the body, leading to various disease conditions. There are over 70 autoimmune diseases including rheumatoid arthritis (RA), multiple sclerosis (MS) and psoriasis. It has been estimated that the prevalence rate of multiple sclerosis in Europe is 83 out of 100,000. Moreover, it is more common among women than men. In addition to this, two million people in Europe are affected by RA, which is one of the most common forms of autoimmune diseases, affecting 21 million people worldwide. However, the societal burden of autoimmune diseases is difficult to estimate as most of these diseases are debilitating, while some are less serious. "The growing patient population and the need for better treatment options are the major driving forces in the autoimmune diseases therapeutics market in Europe," notes the analyst of this research service. "The increased uptake of biologics by physicians is also likely to have a significant impact on the sales of autoimmune disease therapeutics." In addition, aggressive educational campaigns undertaken by pharmaceutical companies to promote new biologics are igniting interest among physicians and are expected to contribute to an increase in market revenues. Awareness Programmes Crucial for Market Growth Currently, the huge gap that exists between early diagnosis and the initiation of therapy is a critical factor restraining market growth. "The complex nature of autoimmune diseases hinders the development of drugs that can cure these diseases," explains the analyst. "This scenario is worsened by low awareness of autoimmune diseases among patients, as well as physicians." Thus, immense scope exists for improvement in translating the current knowledge of the autoimmune diseases to produce efficient therapeutics that can address the symptoms, as well as cure the disease." Accordingly, researchers are striving to develop better therapeutics to reduce the burden of autoimmune diseases. Meanwhile, various continuous medical education programmes will need to be conducted to inform the community about the implications of autoimmune diseases. These initiatives will promote the treatment of those affected with rheumatoid arthritis or multiple sclerosis and some form of drug for such autoimmune diseases can be administered to them. |
More Europe Autoimmune Reports
European Market for Nutritional Solutions in Immune and Antihypertensive Health by
Frost & Sullivan
This research service tracks the key trends in the European immune and antihypertensive health ingredients markets, while also quantifying most of the ingredient markets in ...
European Autoimmune Disease Diagnostics Market by
Frost & Sullivan
This research service gives a detailed analysis of the autoimmune disease diagnostics market within Europe from ...
Strategic Analysis of the Autoimmune Disease Diagnostics Market in Europe by
Frost & Sullivan
Autoimmune Testing Market Becomes the New Source of Growth for In Vitro Diagnostics Companies
Due to stagnating revenue growth and reimbursement pressures, in ...
See all reports like this >>
More Europe Reports
A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
See all reports like this >>
Related Markets
Autoimmune Reports
- Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
- Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success
- Liver Disease Treatments: The Global Market
- Celiac Disease - Pipeline Assessment and Market Forecasts to 2019
- Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
